Crossmark

Imipramine treatment reverses depressive- and anxiety-like behaviors, normalize adrenocorticotropic hormone, and reduces interleukin-1β in the brain of rats subjected to experimental periapical lesion

Crossref DOI link: https://doi.org/10.1016/j.pharep.2018.08.003

Published Print: 2019-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Simões, Lutiana R.

Netto, Soraia

Generoso, Jaqueline S.

Ceretta, Renan A.

Valim, Rodrigo F.

Dominguini, Diogo

Michels, Monique https://orcid.org/0000-0001-8440-1976
Réus, Gislaine Z.

Valvassori, Samira S.

Dal-Pizzol, Felipe

Barichello, Tatiana
Funding

Funding for this research was provided by:

Department of Psychiatry and Behavioral Sciences

McGovern Medical School

The University of Texas Health Science Center at Houston
License Information

Text and Data Mining valid from 2019-02-01
More Information

This article is maintained by: Elsevier

Article Title: Imipramine treatment reverses depressive- and anxiety-like behaviors, normalize adrenocorticotropic hormone, and reduces interleukin-1β in the brain of rats subjected to experimental periapical lesion

Journal Title: Pharmacological Reports

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pharep.2018.08.003

Content Type: article

Copyright: © 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.

Document is current

Any future updates will be listed below